Paracrine/autocrine control of female reproduction

References

• Huhtaniemi IT, Warren DW. Ontogeny of pituitary-gonadal interactions: current advances and controversies. Trends Endocrinol Metab 1990; 1: 356
   Google Scholar
• Ojeda SR, Ma YJ, Rage F. The transforming growth factor alpha gene family is involved in the neuroendocrine control of mammalian puberty. Mol Psychiatry 1997; 2: 355–8
   PubMed Web of Science ®Google Scholar
• Chehab FF, Mounzih K, Lu R, et al. Early onset of reproductive function in normal female mice treated with leptin. Science 1997; 275: 88–90
   PubMed Web of Science ®Google Scholar
• Bhat GK, Mahesh VB, Ping L, et al. Opioidglutamate-nitric oxide connection in the regulation of luteinizing hormone secretion in the rat. Endocrinology 1998; 139: 955–60
   Google Scholar
• McCann SM, Ojeda SR. The anterior pituitary and hypothalamus. Textbook of Endocrine Physiology 3rd edn., JE Griffin, SR Ojeda. Oxford University Press, Oxford 1996; 101–33
   Google Scholar
• Olivennes F, Belaisch-Allart J, Emperaire JC, et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000; 73: 314–20
   PubMed Web of Science ®Google Scholar
• Krsmanovic LZ, Martinez-Fuentes AJ, Arora KK, et al. Local regulation of gonadotroph function by pituitary gonadotropin-releasing hormone. Endocrinology 2000; 141: 1187–95
   PubMed Web of Science ®Google Scholar
• Muttukrishna S, Fowler PA, George L, et al. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 1996; 81: 3328–34
   PubMedGoogle Scholar
• Radovick S, Ticknor CM, Nakayama Y, et al. Evidence for direct estrogen regulation of the human gonadotropin-releasing hormone gene. J Clin Invest 1991; 88: 1649–55
   Google Scholar
• Sanno N, Teramoto A, Sugiyama M, et al. Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. In situ hybridization and immuno-histochemical analysis. Harm Res 1998; 50: 11–7
   Google Scholar
• Roberts VJ, Meunier H, Vaughan J, et al. Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 1989; 124: 552–4
   PubMed Web of Science ®Google Scholar
• Corrigan AZ, Bilezikjian LM, Carroll RS, et al. Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 1991; 128: 1682–4
   PubMed Web of Science ®Google Scholar
• Carroll RS, Corrigan AZ, Gharib SD, et al. Inhibin, activin and follistatin: regulation of follicle-stimulating hormone messenger ribonucleic acid levels. Mol Endocrinol 1989; 3: 1969–76
   PubMedGoogle Scholar
• Dalkin AC, Haisenleder DJ, Yasin M, et al. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin. Endocrinology 1996; 137: 548–54
   Google Scholar
• Bilezikjian LM, Corrigan AZ, Blount AL, et al. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. Endocrinology 1996; 137: 4277–84
   Google Scholar
• Bilezikjian LM, Vaughan J, Vale WW. Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. Endocrinology 1993; 133: 2545–53
   Google Scholar
• Kogawa K, Nakamura T, Sugino K, et al. Activin-binding protein is present in pituitary. Endocrinology 1991; 128: 1434–40
   Google Scholar
• Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrinol Rev 1996; 17: 121–55
   PubMed Web of Science ®Google Scholar
• Adashi EY. The IGF family and folliculogenesis. J Reprod Immunol 1998; 39: 13–9
   PubMed Web of Science ®Google Scholar
• Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992; 13: 641–69
   PubMed Web of Science ®Google Scholar
• Zolti M, Meiron R, Shemesh M, et al. Granulosa cells as a source and target organ for tumor necrosis factor-α. FEBS Lett 1990; 261: 253–5
   PubMed Web of Science ®Google Scholar
• Brannstrom M, Norman RJ, Seamark RF, et al. Rat ovary produces cytokines during ovulation. Biol Reprod 1994; 50: 88–94
   Google Scholar
• Henriksen R, Gobl A, Wilander E, et al. Expression and prognostic significance of TGF-β isotypes, latent TGF-β1 binding protein, TGF-β type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab Invest 1995; 73: 213–20
   PubMed Web of Science ®Google Scholar
• Adashi EY, Resnick CE, Packman JN, et al. Cytokine-mediated regulation of ovarian function: Tumor necrosis factor-α inhibits gonadotropin-supported progesterone accumulation by differentiating luteinizing murine granulosa cells. Am J Obstet Gynecol 1990; 162: 889–99
   PubMed Web of Science ®Google Scholar
• Fukuoka M, Tori T, Tah S, et al. Interleukin-1 inhibits luteinization of porcine granulosa cells in culture. Endocrinology 1988; 122: 367–9
   Google Scholar
• Kenecht M, Feng P, Catt KJ. Bifunctional role of transforming growth factor-beta during granulosa cell development. Endocrinology 1987; 120: 1243–9
   Google Scholar
• Hofmann GE, Danforth DR, Seifer DB. Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 1998; 69: 474–7
   PubMed Web of Science ®Google Scholar
• Ballester MJ, Serrano MD, Mir A, et al. Aetiologic factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone. Hum Reprod 1994; 9: 806–11
   Google Scholar
• Omura T, Morohashi K. Gene regulation of steroidogenesis. J Steroid Biochem Mol Biol 1995; 53: 19–25
   PubMed Web of Science ®Google Scholar
• Urban RJ, Bodenburg YH, Nagamani M, et al. Dexamethasone potentiates IGF-I actions in porcine granulosa cells. Am J Physiol 1997; 267: E115–23
   Google Scholar
• Tetsuka M, Thomas FJ, Thomas MJ, et al. Differential expression of messenger ribonucleic acids encoding 11β-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells. J Clin Endocrinol Metab 1997; 82: 2006–9
   Google Scholar
• Hillier SG, Tetsuka M. An anti-inflammatory role for glucocorticoids in the ovaries?. J Reprod Immunol 1998; 39: 21–7
   PubMed Web of Science ®Google Scholar
• Vale W, Rivier C, Hsueh AJW, et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1988; 44: 1–34
   PubMedGoogle Scholar
• Li R, Phillips DM, Mather JP. Activin promotes ovarian follicle development in vitro. Endocrinology 1995; 136: 849–56
   Google Scholar
• Miro F, Hillier SG. Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin. Endocrinology 1996; 137: 464–8
   Google Scholar
• Xiao S, Robertson DM, Findlay JK. Effects of activin and follicle-stimulating hormone (FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells. Endocrinology 1992; 131: 1009–16
   Google Scholar
• Hillier SG, Yong EL, Illingworth PJ, et al. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 1991; 75: R1–6
   PubMed Web of Science ®Google Scholar
• Burger HG, Baile A, Drummond AE, et al. Inhibin and ovarian cancer. J Reprod Immunol 1998; 39: 77–87
   Google Scholar
• Petraglia F, Luisi S, Pautier P, et al. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J Clin Endocrinol Metab 1998; 83: 1029–32
   Google Scholar
• Bulletti C, De Ziegler D, Flamigni C, et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod 1997; 12: 1073–9
   PubMed Web of Science ®Google Scholar
• Fisher SJ, Damsky CH. Human cytotrophoblast invasion. Sem Cell Biol 1993; 4: 183–8
   PubMedGoogle Scholar
• Giudice LC. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine. Fertil Steril 1994; 61: 1–17
   PubMed Web of Science ®Google Scholar
• Giudice LC, Mark SP, Irwin JC. Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface. J Reprod Immunol 1998; 39: 133–48
   PubMed Web of Science ®Google Scholar
• Licht P, Losch A, Dittrich R, et al. Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum Reprod Update 1998; 4: 532–8
   PubMed Web of Science ®Google Scholar
• Gold LI, Saxena B, Mittal KR, et al. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: Evidence for paracrine and autocrine action. Cancer Res 1994; 54: 2347–58
   PubMed Web of Science ®Google Scholar
• Chegini N, Zhao Y, Williams RS, et al. Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-β1 (TGFβ1), TGFβ2, TGFβ3, and TGFβ type II receptor messenger ribonucleic acid and protein and contains [125I]TGFβ1-binding sites. Endocrinology 1994; 135: 439–49
   PubMed Web of Science ®Google Scholar
• Marshburn PB, Arid A, Casey ML. Expression of transforming growth factor-beta 1 messenger ribonucleic acid and the modulation of deoxyribonucleic acid synthesis by transforming growth factor-beta 1 in human endometrial cells. Am J Obstet Gynecol 1994; 170: 1152–8
   Google Scholar
• Tang B, Zhao Y, Rossi MJ, et al. Expression of transforming growth factor-beta (TGF beta) isoforms and TGF beta type II receptor messenger ribonucleic acid and protein, and the effect of TGF beta on endometrial stromal cell growth and protein degradation in vitro. Endocrinology 1994; 135: 450–9
   Google Scholar
• Kim YJ, Ahn JJ, Woo BH. The effect of cytokine mediators on prostaglandin inhibition by human decidual cells. Am J Obstet Gynecol 1998; 179: 146–9
   Google Scholar
• Bruner KL, Rodgers WH, Gold LI, et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995; 92: 7362–6
   PubMed Web of Science ®Google Scholar
• Casey ML, MacDonald PC. Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells. J Clin Endocrinol Metab 1996; 81: 4022–7
   PubMed Web of Science ®Google Scholar
• Perlino E, Loverro G, Maiorano E, et al. Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma. Br J Cancer 1998; 77: 1260–6
   PubMed Web of Science ®Google Scholar
• Petraglia F, Florio P, Luisi S, et al. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab 1998; 83: 1194–200
   Google Scholar
• Wu WX, Brooks J, Millar MR, et al. Localization of the sites of synthesis and action of prolactin by immunocytochemistry and in-situ hybridization within the human utero-placental unit. J Mol Endocrinol 1991; 7: 241–7
   Google Scholar
• Tanaka S, Koibuchi N, Ohtake H, et al. Regional comparison of prolactin gene expression in the human decidualized endometrium in early and term pregnancy. Eur J Endocrinol 1996; 135: 177–83
   Google Scholar
• Tabanelli S, Tang B, Gurpide E. In vitro decidualization of human endometrial stromal cells. J Steroid Biochem Mol Biol 1992; 42: 337–44
   Google Scholar
• Daly DC, Maslar IA, Riddick DH. Prolactin production during in vitro decidualization of proliferative endometrium. Am J Obstet Gynecol 1983; 145: 672–8
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, Mershon JL, Allen DL, et al. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996; 17: 639–69
   PubMed Web of Science ®Google Scholar
• Wu WX, Brooks J, Glasier AF, et al. The relationship between decidualization and prolactin mRNA and production at different stages of human pregnancy. J Mol Endocrinol 1995; 14: 255–61
   PubMed Web of Science ®Google Scholar
• Aubert ML, Grumbach MM, Kaplan SL. The ontogenesis of human fetal hormones. III. Prolactin. J Clin Invest 1975; 56: 155–64
   PubMed Web of Science ®Google Scholar
• Johnson JWC, Tyson JE, Mitzner W, et al. Aminiotic fluid prolactin and fetal lung maturation. Am J Obstet Gynecol 1985; 153: 372–80
   Google Scholar
• Tyson JE. The evolutionary role of prolactin in mammalian osmoregulation: effects on fetoplacental hydromineral transport. Sem Perinatol 1982; 6: 216–28
   Google Scholar
• Healy DL. The clinical significance of endometrial prolactin. Aust NZ J Obstet Gynaecol 1984; 24: 111–6
   Google Scholar
• Frasor J, Gaspar CA, Donnelly KM, et al. Expression of prolactin and its receptor in the baboon uterus during the menstrual cycle and pregnancy. J Clin Endocrinol Metab 1999; 84: 3344–50
   Google Scholar
• Gonzalez RR, Palomino A, Boric A, et al. A quantitative evaluation of alpha1, alpha4, alphaV and beta3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal. Hum Reprod 1999; 14: 2485–92
   PubMedGoogle Scholar
• Tabibzadeh S, Zupi E, Babaknia A, et al. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Hum Reprod 1995; 10: 277–86
   Google Scholar
• Singer CF, Marbaix E, Lemoine P, et al. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 1999; 259: 40–5
   PubMedGoogle Scholar
• Petraglia F, Florio P, Nappi C, et al. Peptide signaling in human placenta and membranes: Autocrine, paracrine, and endocrine mechanisms. Endocrc Rev 1996; 17: 156–86
   PubMed Web of Science ®Google Scholar
• Morrish DW, Dakour J, Li H. The trophoblast as an active regulator of the pregnancy environment in health and disease: an emerging concept. Advances in Organ Biology, T Zakar. JAI Press, Greenwich 2000; 121–52
   Google Scholar
• Bischof P, Campana A. A model for implantation of the human blastocyst and early placentation. Hum Reprod Update 1996; 2: 262–70
   Google Scholar
• Morrish DW, Linetsky E, Bhardwaj D, et al. Identification by subtractive hybridization of a spectrum of novel and unexpected genes associated with in vitro differentiation of human cytotrophoblast cells. Placenta 1996; 17: 431–41
   PubMedGoogle Scholar
• Petraglia F. Sawchenko P, Lim ATW, et al. Localization, secretion, and action of inhibin in human placenta. Science 1987; 237: 187–9
   Google Scholar
• Steele GL, Currie WD, Yuen BH, et al. Acute stimulation of human chorionic gonadotropin secretion by recombinant human activin-A in first trimester human trophoblast. Endocrinology 1993; 133: 297–303
   Google Scholar
• Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989; 160: 247–51
   PubMed Web of Science ®Google Scholar
• Petraglia F, Gallinelli A, Grande A, et al. Local production and action of follistatin in human placenta. J Clin Endocrinol Metab 1994; 78: 205–10
   PubMedGoogle Scholar
• Barbieri RL. The maternal adenohypophysis. Maternal–Fetal Endocrinology 2nd edn., D Tulchinsky, AB Little. WB Saunders Co., Philadelphia 1994
   Google Scholar
• Petraglia F, Luisi S, Benedetto C, et al. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab 1997; 82: 2991–5
   PubMedGoogle Scholar
• Petraglia F, Vaughan J, Vale W. Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. J Clin Endocrinol Metab 1990; 70: 1173–8
   PubMed Web of Science ®Google Scholar
• Siler-Khodr TM, Khodr GS, Rhode J, et al. Gestational age related inhibition of placental hCG and steroid hormone release in vitro by a GnRH antagonist. Placenta 1987; 8: 1–14
   Google Scholar
• Barnea ER, Ashkenazi R, Sarne Y. The effect of dynorphin on placental pulsatile hCG secretion in vitro. J Clin Endocrinol Metab 1991; 73: 1093–8
   Google Scholar
• Barnea ER, Ashkenazi R, Tal Y, et al. Effect of β-endorphin on human chorionic gonadotrophin secretion by placental explants. Hum Reprod 1991; 6: 1327–31
   Google Scholar
• Morrish DW, Bhardwaj D, Paras MT. Transforming growth factor-1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology 1991; 129: 22–6
   Google Scholar
• Bhaumick B, Dawson EP, Bala RM. The effects of insulin-like growth factor I and insulin on placental lactogen production by human term placental explants. Biochem Biophys Res Commun 1987; 144: 674–82
   PubMedGoogle Scholar
• Petraglia F, Sawchenko PE, Rivier J, et al. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987; 328: 717–9
   PubMed Web of Science ®Google Scholar
• Florio P, Lombardo M, Gallo R, et al. Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. Placenta 1996; 17: 307–11
   PubMedGoogle Scholar
• Griffing GT, Melby JC. The maternal adrenal cortex. Maternal–Fetal Endocrinology 2nd edn., D Tulchinsky, AB Little. WB Saunders Co, Philadelphia 1994; 119–30
   Google Scholar
• Petraglia F, Anceschi MM, Calzà L, et al. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993; 77: 542–8
   PubMed Web of Science ®Google Scholar
• Petraglia F, Benedetto C, Florio P, et al. Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro. J Clin Endocrinol Metab 1995; 80: 3073–6
   PubMedGoogle Scholar